Edition:
United States

People: Trovagene Inc (TROV.OQ)

TROV.OQ on NASDAQ Stock Exchange Capital Market

3.37USD
18 Apr 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$3.37
Open
$3.34
Day's High
$3.44
Day's Low
$3.31
Volume
17,894
Avg. Vol
150,892
52-wk High
$25.13
52-wk Low
$2.54

Markin, Rodney 

Dr. Rodney S. Markin, M.D., Ph.D. is Independent Director of Trovagene, Inc. Dr. Markin is Chief Technology Officer and Associate Vice Chancellor for Business Development at the University of Nebraska Medical Center and a Professor of Pathology and Microbiology; David T. Purtilo Distinguished Professor Pathology and Microbiology and Courtesy Professor of Surgery. Dr. Markin is also a director on the Board of Children’s Hospital and Medical Center Foundation and on the Board of Trustees for Keck Graduate Institute and on the Board of the Make-A-Wish Foundation. The Board selected Dr. Markin to serve as a director because he has valuable executive experience in the healthcare business.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --